Potential role of the cell-penetrating peptide-conjugated soluble N-ethylmaleimide-sensitive factor attachment protein receptor motif of vesicle-associated membrane protein 2-patterned peptide in novel cosmeceutical skin product development.

cell-penetrating peptide cosmetics skin aging soluble N-ethylmaleimide-sensitive factor attachment protein receptor synthetic peptide

Journal

Journal of cosmetic dermatology
ISSN: 1473-2165
Titre abrégé: J Cosmet Dermatol
Pays: England
ID NLM: 101130964

Informations de publication

Date de publication:
12 Sep 2023
Historique:
revised: 26 07 2023
received: 08 05 2023
accepted: 21 08 2023
pubmed: 12 9 2023
medline: 12 9 2023
entrez: 12 9 2023
Statut: aheadofprint

Résumé

This study aimed to investigate and verify the effect of cell-penetrating peptide (CPP)-conjugated soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) motif of vesicle-associated membrane protein 2 (VAMP2)-patterned peptide (INCI name: Acetyl sh-Oligopeptide-26 sh-Oligopeptide-27 SP, trade name: M.Biome-BT) on improving skin function in vitro. The cytotoxicity of CPP-conjugated SNARE motif of VAMP2-patterned peptide (CVP) was investigated using the 3-(4,5-dimethylthiazol-2yl)-2,5-diphenyl tetrazolium bromide (MTT) assay against B16-F10 cells and human dermal fibroblasts (HDFs) and a reconstructed skin irritation test. The anti-wrinkle activity of M.Biome-BT was determined by assessing the release of norepinephrine and dopamine in PC-12 cells via ELISA. The skin-whitening effects of CVP were assessed in B16-F10 cells by measuring the intra- and extracellular melanin contents and expression levels of melanin production-related genes, such as microphthalmia-associated transcription factor (MITF), tyrosinase (TYR), tyrosinase-related protein-1 (TRP-1), and TRP-2. CVP is not cytotoxic to B16-F10 cells and HDFs, and no skin irritation was observed. CVP treatment considerably diminished K Taken together, our findings indicate that CVP could be used as an active and safe cosmeceutical ingredient for antiaging applications.

Identifiants

pubmed: 37698157
doi: 10.1111/jocd.15984
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Medytox Inc

Informations de copyright

© 2023 Medytox Inc. Journal of Cosmetic Dermatology published by Wiley Periodicals LLC.

Références

Amer RI, El-Osaily GH, Bakr RO, El Dine RS, Fayez AM. Characterization and pharmacological evaluation of anti-cellulite herbal product(s) encapsulated in 3D-fabricated polymeric microneedles. Sci Rep. 2020;10(1):6316. doi:10.1038/s41598-020-63271-6
Zhang S, Duan E. Fighting against skin aging: the way from bench to bedside. Cell Transplant. 2018;27(5):729-738. doi:10.1177/0963689717725755
Rona C, Vailati F, Berardesca E. The cosmetic treatment of wrinkles. J Cosmet Dermatol. 2004;3(1):26-34. doi:10.1111/j.1473-2130.2004.00054.x
Wongrattanakamon P, Nimmanpipug P, Sirithunyalug B, Jiranusornkul S. Molecular modeling elucidates the cellular mechanism of synaptotagmin-SNARE inhibition: a novel plausible route to anti-wrinkle activity of botox-like cosmetic active molecules. Mol Cell Biochem. 2018;442(1-2):97-109. doi:10.1007/s11010-017-3196-5
Kim M, Shin S, Lee JA, Park D, Lee J, Jung E. Inhibition of melanogenesis by Gaillardia aristata flower extract. BMC Complement Altern Med. 2015;15:449. doi:10.1186/s12906-015-0972-1
Maddodi N, Jayanthy A, Setaluri V. Shining light on skin pigmentation: the darker and the brighter side of effects of UV radiation. Photochem Photobiol. 2012;88(5):1075-1082. doi:10.1111/j.1751-1097.2012.01138.x
Jung CH, Yang YS, Kim JS, et al. A search for synthetic peptides that inhibit soluble N-ethylmaleimide sensitive-factor attachment receptor-mediated membrane fusion. FEBS J. 2008;275(12):3051-3063. doi:10.1111/j.1742-4658.2008.06458.x
Yamauchi PS, Lask G, Lowe NJ. Botulinum toxin type A gives adjunctive benefit to periorbital laser resurfacing. J Cosmet Laser Ther. 2004;6(3):145-148. doi:10.1080/14764170410023767
Jung JA, Kim BJ, Kim MS, et al. Protective effect of botulinum toxin against ultraviolet-induced skin pigmentation. Plast Reconstr Surg. 2019;144(2):347-356. doi:10.1097/PRS.0000000000005838
Resende D, Ferreira MS, Sousa-Lobo JM, Sousa E, Almeida IF. Usage of synthetic peptides in cosmetics for sensitive skin. Pharmaceuticals (Basel). 2021;14(8):702. doi:10.3390/ph14080702
Zhao X, Zhang X, Liu D. Collagen peptides and the related synthetic peptides: a review on improving skin health. J Funct Foods. 2021;86:104680.
Koren E, Torchilin VP. Cell-penetrating peptides: breaking through to the other side. Trends Mol Med. 2012;18(7):385-393. doi:10.1016/j.molmed.2012.04.012
Desai P, Patlolla RR, Singh M. Interaction of nanoparticles and cell-penetrating peptides with skin for transdermal drug delivery. Mol Membr Biol. 2010;27(7):247-259. doi:10.3109/09687688.2010.522203
Gautam A, Nanda JS, Samuel JS, et al. Topical delivery of protein and peptide using novel cell penetrating peptide IMT-P8. Sci Rep. 2016;6:26278. doi:10.1038/srep26278
Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65(1-2):55-63. doi:10.1016/0022-1759(83)90303-4
OECD. OECD Guidelines for the Testing of Chemicals No. 439: in vitro Skin Irritation Reconstructed Human Epidermis Test Method. doi:10.1787/9789264090958-en
Yoon WJ, Kim MJ, Moon JY, et al. Effect of palmitoleic acid on melanogenic protein expression in murine b16 melanoma. J Oleo Sci. 2010;59(6):315-319. doi:10.5650/jos.59.315
Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25(4):402-408. doi:10.1006/meth.2001.1262
Ray P, Berman JD, Middleton W, Brendle J. Botulinum toxin inhibits arachidonic acid release associated with acetylcholine release from PC12 cells. J Biol Chem. 1993;268(15):11057-11064.
Khawaja HA, Hernandez-Perez E. Botox in dermatology. Int J Dermatol. 2001;40(5):311-317. doi:10.1046/j.1365-4362.2001.01176.x
Huang W, Foster JA, Rogachefsky AS. Pharmacology of botulinum toxin. J Am Acad Dermatol. 2000;43(2 Pt 1):249-259. doi:10.1067/mjd.2000.105567
Wang Y, Wang M, Xiao XS, Pan P, Li P, Huo J. The anti wrinkle efficacy of synthetic hexapeptide (Argireline) in Chinese Subjects. J Cosmet Laser Ther. 2013. doi:10.3109/14764172.2012.759234. Online ahead of print.
Delevoye C. Melanin transfer: the keratinocytes are more than gluttons. J Invest Dermatol. 2014;134(4):877-879. doi:10.1038/jid.2013.487
Ando H, Niki Y, Ito M, et al. Melanosomes are transferred from melanocytes to keratinocytes through the processes of packaging, release, uptake, and dispersion. J Invest Dermatol. 2012;132(4):1222-1229. doi:10.1038/jid.2011.413
Scott G, Zhao Q. Rab3a and SNARE proteins: potential regulators of melanosome movement. J Invest Dermatol. 2001;116(2):296-304. doi:10.1046/j.1523-1747.2001.01221.x

Auteurs

Hyo Jin Lee (HJ)

Gwanggyo R&D Center, Medytox Inc., Suwon-si, Korea.

Daehoon Kim (D)

Gwanggyo R&D Center, Medytox Inc., Suwon-si, Korea.

Hyo Jeong Choi (HJ)

Gwanggyo R&D Center, Medytox Inc., Suwon-si, Korea.

Suhyeok Kim (S)

Gwanggyo R&D Center, Medytox Inc., Suwon-si, Korea.

Minhee Shin (M)

Gwanggyo R&D Center, Medytox Inc., Suwon-si, Korea.

Seongsung Kwak (S)

Gwanggyo R&D Center, Medytox Inc., Suwon-si, Korea.

Dong-Kyu Lee (DK)

Gwanggyo R&D Center, Medytox Inc., Suwon-si, Korea.

Won-Ho Kang (WH)

Gwanggyo R&D Center, Medytox Inc., Suwon-si, Korea.

Classifications MeSH